99% Savings - Buy Just @1 Rs X
Glimixia, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes.
Medical history of the patient along with age and gender determines the dosage of Glimixia. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Glimixia have been listed ahead. Such side effects of Glimixia normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Glimixia has a Moderate effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Glimixia's effects on the liver, heart and kidney, if any, have been listed below.
Glimixia is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Liver Disease, Kidney Disease are examples of such conditions. Some other conditions that can be affected by Glimixia are listed in the contraindications section below.
Besides this, Glimixia may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Glimixia is safe while driving, and is is addictive in nature.
Glimixia is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimixia safe for pregnant women?
Glimixia may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Glimixia again without your doctor's advice.
Is the use of Glimixia safe during breastfeeding?
There is no research available on the side effects of Glimixia in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Glimixia on the Kidneys?
Kidney can be affected by Glimixia. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glimixia on the Liver?
Glimixia may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimixia on the Heart?
Glimixia has very mild side effects on the heart.
Glimixia should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glimixia unless your doctor advises you to do so -
Is this Glimixia habit forming or addictive?
Glimixia is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Glimixia since it will not make you feel sleepy.
Is it safe?
Yes, Glimixia is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Glimixia in mental disorders is not effective.
Interaction between Food and Glimixia
There is no information on the effects of taking Glimixia with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimixia
Consuming Glimixia with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158